Host sphingolipid biosynthesis as a target for hepatitis C virus therapy (Q40330820)

19 September 2017

title

Host sphingolipid biosynthesis as a target for hepatitis C virus therapy (English)

1 reference

19 September 2017

1 reference

1 reference

Hiroshi Sakamoto

1 reference

19 September 2017

Koichi Okamoto

1 reference

19 September 2017

Masahiro Aoki

1 reference

19 September 2017

Hideyuki Kato

1 reference

19 September 2017

Asao Katsume

1 reference

19 September 2017

Atsunori Ohta

1 reference

19 September 2017

Takuo Tsukuda

1 reference

19 September 2017

Nobuo Shimma

1 reference

19 September 2017

Yuko Aoki

1 reference

19 September 2017

Mikio Arisawa

1 reference

19 September 2017

Michinori Kohara

1 reference

19 September 2017

Masayuki Sudoh

1 reference

19 September 2017

publication date

16 October 2005

1 reference

19 September 2017

published in

Nature Chemical Biology

1 reference

19 September 2017

1 reference

19 September 2017

1 reference

19 September 2017

page(s)

333-337

1 reference

Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. International Hepatitis Interventional Therapy Group

19 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO742

Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO742

An NS3 protease inhibitor with antiviral effects in humans infected with hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO742

In vitro resistance studies of hepatitis C virus serine protease inhibitors, VX-950 and BILN 2061: structural analysis indicates different resistance mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO742

Nonlinear partial differential equations and applications: Genomic analysis of the host response to hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO742

Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO742

Control of PKR protein kinase by hepatitis C virus nonstructural 5A protein: molecular mechanisms of kinase regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO742

Serine palmitoyltransferase is the primary target of a sphingosine-like immunosuppressant, ISP-1/myriocin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO742

Human and murine serine-palmitoyl-CoA transferase--cloning, expression and characterization of the key enzyme in sphingolipid synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO742

Acylation of naturally occurring and synthetic 1-deoxysphinganines by ceramide synthase. Formation of N-palmitoyl-aminopentol produces a toxic metabolite of hydrolyzed fumonisin, AP1, and a new category of ceramide synthase inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO742

A novel inhibitor of ceramide trafficking from the endoplasmic reticulum to the site of sphingomyelin synthesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO742

Characterization of the hepatitis C virus RNA replication complex associated with lipid rafts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO742

Hepatitis C Virus RNA Replication Occurs on a Detergent-Resistant Membrane That Cofractionates with Caveolin-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO742

Functional rafts in cell membranes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO742

Specific interaction of HIV-1 and HIV-2 surface envelope glycoproteins with monolayers of galactosylceramide and ganglioside GM3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO742

Identification of a common sphingolipid-binding domain in Alzheimer, prion, and HIV-1 proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO742

Ceramide, a target for antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO742

Disruption of hepatitis C virus RNA replication through inhibition of host protein geranylgeranylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO742

Hepatitis C virus RNA replication is regulated by host geranylgeranylation and fatty acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO742

The crystal structure of hepatitis C virus NS3 proteinase reveals a trypsin-like fold and a structural zinc binding site

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO742

Crystal structure of the RNA-dependent RNA polymerase from hepatitis C virus reveals a fully encircled active site

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO742

Interactions between viral nonstructural proteins and host protein hVAP-33 mediate the formation of hepatitis C virus RNA replication complex on lipid raft

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO742

The natural history of hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO742

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/NCHEMBIO742

1 reference

release_oa2uw2ig6jan3apdnjidgo52le

19 September 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/oa2uw2ig6jan3apdnjidgo52le

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference